Eltacin pills sublingual 30 pieces
Condition: New product
996 Items
Rating:
Be the first to write a review!
More info
Active ingredients
Glutamic acid
Release form
Pills
Composition
Active ingredient: Glycine + Glutamic acid + Cystine (Glycinum + Acidum glutaminicum + Cystinum) Active ingredient concentration (mg): L-Cystine - 70 mg; L-Glutamic acid - 70 mg, Glycine - 70 mg,
Pharmacological effect
Antioxidant drug. Eltacin is a combined drug that contains a mixture of replaceable amino acids: glycine, glutamic acid and cystine, which are metabolic regulators: they increase the intracellular concentration of glutathione and the activity of glutathione-dependent enzymes that normalize redox processes and oxygen utilization in tissues, due to which the drug: - shows antioxidant (reducing the content of free radicals, peroxide compounds, malonic dialdehyde) and antihypoxant (increasing the body’s resistance oxygen deficiency, enhancing the synthesis of adenosine triphosphate (ATP) action; increases myocardial contractility, increases physical performance, improves the quality of life of patients with chronic heart failure (increasing social adaptation, improving psycho-emotional state), accelerates recovery of health after intensive physical exertion in children.
Indications
Syndrome of autonomic dysfunction in children aged 12 years. Chronic heart failure I-III functional class according to NYHA classification in adults (against the background of standard therapy). Chronic heart failure I-II functional class according to NYHA classification in children aged 12 to 18 years (against the background of standard therapy). Prevention of chronic physical overstrain and recovery after intense physical exertion when playing sports in children aged 11 to 15 years.
Contraindications
Hypersensitivity to the drug, children under 11 years of age (efficacy and safety have not been established).
Use during pregnancy and lactation
Clinical studies of the drug in pregnant women and during lactation has not been conducted. Not recommended for use during pregnancy and lactation.
Dosage and administration
Sublingual.The tablet can also be chewed and held in the mouth under the tongue until completely dissolved. Syndrome of vegetative dysfunction in children aged 12 years: 1 tablet 3 times a day sublingual, treatment from 1 to 3 months depending on the severity of the disease, repeated courses are prescribed on the recommendation of a doctor. Chronic heart failure I-III functional class according to the NYHA classification in adults: 1 tablet 3 times a day sublingual, a course of treatment from 1 to 3 months depending on the severity of the disease, repeated courses are prescribed Doctor's recommendations. Chronic heart failure of the I-II functional class according to the NYHA classification in children aged 12 to 18 years: 1 tablet 3 times a day sublingual, treatment from 1 to 3 months depending on the severity of the disease, repeated courses are prescribed doctor's recommendations. Prevention of chronic physical overstrain in children aged 11 to 15 years: 1 tablet 2 times a day for 2-3 weeks. In the recovery period after intense physical exertion when playing sports in children aged 11 to 15 years - 1 ta 3 times a day for 2 weeks.
Side effects
Allergic reactions are possible.
Overdose
No data.
Interaction with other drugs
No information available.
special instructions
Can be taken simultaneously with ACE inhibitors, beta-blockers, diuretics, aldosterone antagonists, organic nitrates and slow calcium channel blockers.